You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • FRI0374 Outcomes in Systemic Lupus Erythematosus Patients with High Disease Activity Treated with Belimumab: 18 Month Results from the US Observe Study

Citation Tools

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Poster Presentations. SLE, Sjögren's and APS - treatment
FRI0374 Outcomes in Systemic Lupus Erythematosus Patients with High Disease Activity Treated with Belimumab: 18 Month Results from the US Observe Study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Collins C, Dall'Era M, Macahilig C, et al
FRI0374 Outcomes in Systemic Lupus Erythematosus Patients with High Disease Activity Treated with Belimumab: 18 Month Results from the US Observe Study
Annals of the Rheumatic Diseases 2014;73:522.